MID
Drug
Novartis Pharma AG
Total Payments
$4.0M
Transactions
4
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $2.7M | 2 | 0 |
| 2017 | $1.3M | 2 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $4.0M | 4 | 100.0% |
Top Doctors Receiving Payments for MID
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Boston, MA | $4.0M | 4 |
Ad
Manufacturing Companies
- Novartis Pharma AG $4.0M
Product Information
- Type Drug
- Total Payments $4.0M
- Total Doctors 0
- Transactions 4
About MID
MID is a drug associated with $4.0M in payments to 0 healthcare providers, recorded across 4 transactions in the CMS Open Payments database. The primary manufacturer is Novartis Pharma AG.
Payment data is available from 2017 to 2018. In 2018, $2.7M was paid across 2 transactions to 0 doctors.
The most common payment nature for MID is "Royalty or License" ($4.0M, 100.0% of total).